Loading organizations...
SKK Ventures, an investment arm of Shepherd Kaplan Krochuk, builds its portfolio by targeting platform technology projects featuring defensible intellectual property. Its strategy involves venture capital and opportunistic private equity, primarily focusing on the healthcare and technology sectors. The firm invests in companies positioned to generate multiple, diversified revenue streams.
Shepherd Kaplan Krochuk was co-founded in 1998 by David Shepherd and David Kaplan. Their initial vision was to create an independent financial advisory firm, evolving into a registered investment advisor offering institutional-grade wealth management and investment services. This foundational expertise guides SKK Ventures' disciplined approach to identifying promising opportunities.
SKK Ventures offers growth opportunities for its parent company's private clients in the dynamic technology and healthcare markets. Its vision is to select and nurture ventures demonstrating significant potential for long-term value creation, thereby reinforcing Shepherd Kaplan Krochuk's commitment to sophisticated fiduciary management and diversified investment strategies.
Key people at SKK Ventures.
SKK Ventures was founded in 2001 by Brian Lockhart (Founder) and David Kaplan (Founder) and David Shepherd (Founder) and Stephen Brackett (Founder) and Tim Krochuk (Founder).
Key people at SKK Ventures.
SKK Ventures was founded in 2001 by Brian Lockhart (Founder) and David Kaplan (Founder) and David Shepherd (Founder) and Stephen Brackett (Founder) and Tim Krochuk (Founder).
SKK Ventures has 2 tracked investments across 2 companies. The latest tracked deal is $39.0M Series B in Windgap Medical in January 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 21, 2022 | Windgap Medical | $39.0M Series B | — | Cobro Ventures, Molex Ventures |
| Jul 1, 2020 | NanoDx | $18.0M Series C | SKK Ventures | — |